Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 24 May 2022 for PhaseBio Pharmaceuticals Inc, €7,244. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Glen Burkhardt: trading record in brief
Glen Burkhardt, listed as senior executive, appears in our data through filings on PhaseBio Pharmaceuticals Inc shares, published by SEC (Form 4). Between 20 May 2021 and 20 May 2022, the trades on record add up to 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 24 May 2022, reports a share grant of €7,244 in PhaseBio Pharmaceuticals Inc. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Glen Burkhardt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
11,248 shares@ US$0.681316.1% of flowCommon StockSEC:0001169245-22-000077:0
5,766 shares@ US$2.0139.0% of flowCommon StockSEC:0001169245-21-000125:0
3,811 shares@ US$2.8033.4% of flowCommon StockSEC:0001169245-21-000046:0
3 of 3 declarations
